Bayesian Capital Management’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-302,600
Closed -$1.07M 738
2024
Q4
$1.07M Buy
+302,600
New +$1.21M 0.13% 220
2018
Q3
Sell
-24,000
Closed -$82K 688
2018
Q2
$82K Sell
24,000
-34,800
-59% -$133K 0.02% 560
2018
Q1
$250K Buy
+58,800
New +$159K 0.06% 442

Other funds holding GERN

Bayesian Capital Management's GERN Position: Q1 2025 in Review

Bayesian Capital Management sold out of Geron (GERN) in Q1 2025, closing a stake of 302,600 shares — an estimated $1.07M sold.

Bayesian Capital Management first reported a position in GERN in Q1 2018 and held it in 3 quarters. The position peaked at $1.07M in Q4 2024. 270 funds tracked by Wall St. Rank hold GERN as of Q1 2025.

  • Bayesian Capital Management reported no remaining Geron position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 302,600 Geron shares in Q1 2025, an estimated $1.07M.
  • Bayesian Capital Management first reported a position in Geron in Q1 2018 and held it in 3 quarters.
  • Bayesian Capital Management's Geron position peaked at $1.07M in Q4 2024.
  • 270 funds tracked by Wall St. Rank held Geron as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.